Your browser doesn't support javascript.
loading
Persistence of antienvoplakin and antiperiplakin antibodies in a patient with paraneoplastic pemphigus 20 years after remission.
Riera-Monroig, J; Iranzo, P; Ishii, N; Hashimoto, T; Mascaró, J M.
Affiliation
  • Riera-Monroig J; Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Iranzo P; Department of Dermatology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
  • Ishii N; Department of Dermatology, Kurume University School of Medicine and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan.
  • Hashimoto T; Department of Dermatology, Kurume University School of Medicine and Kurume University Institute of Cutaneous Cell Biology, Fukuoka, Japan.
  • Mascaró JM; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Br J Dermatol ; 182(3): 797-798, 2020 03.
Article in En | MEDLINE | ID: mdl-31529517
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraneoplastic Syndromes / Pemphigus Limits: Humans Language: En Journal: Br J Dermatol Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraneoplastic Syndromes / Pemphigus Limits: Humans Language: En Journal: Br J Dermatol Year: 2020 Document type: Article